Overview
Bin-na Lee practices practicing medicine in Gwangju, Republic of Korea.
Their clinical expertise encompasses Rhabdomyosarcoma, X-Linked Hypophosphatemia, Hypophosphatemia, and Rickets.
They are actively involved in clinical research, co-authoring 50 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Bin-na J. Lee
Is Bin-na J. Lee a top-rated expert for Rhabdomyosarcoma?
MediFind is an objective health platform that identifies experts based on real-world data. Bin-na J. Lee is classified as an Experienced expert for Rhabdomyosarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Bin-na J. Lee participate in research or clinical trials?
Yes. Bin-na J. Lee has published 50 articles and abstracts on conditions like Rhabdomyosarcoma. You can view a list of Bin-na J. Lee's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- HypophosphatemiaLee isExperienced. Learn about Hypophosphatemia.
- RhabdomyosarcomaLee isExperienced. Learn about Rhabdomyosarcoma.
- RicketsLee isExperienced. Learn about Rickets.
- X-Linked HypophosphatemiaLee isExperienced. Learn about X-Linked Hypophosphatemia.